NCT02551497 is a Phase 1 clinical trial of CNV1014802 in Healthy, sponsored by Biogen.

Who is sponsoring NCT02551497?

NCT02551497 is sponsored by Biogen.

What drugs are being tested in NCT02551497?

Interventions in NCT02551497: CNV1014802.

Is NCT02551497 still recruiting?

NCT02551497 is currently completed. Last updated 16 October 2017.

Last reviewed 2017-10-16 · How we verify

NCT02551497

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Completed Phase 1 Last updated 16 October 2017

What this trial tests

Phase 1 trial testing CNV1014802 in Healthy in 36 participants. Completed in 26 August 2016.

Timeline

30 April 2015

Primary endpoint
16 August 2016

26 August 2016

Quick facts

Lead sponsor	Biogen
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	36
Start date	30 April 2015
Primary completion	16 August 2016
Estimated completion	26 August 2016
Sites	1 location across United Kingdom

Drugs / interventions tested

CNV1014802 — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Biogen — full company profile →

Who can join

Adults 18 to 55, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a double-blind, randomised, placebo-controlled 3 period study to evaluate the interaction between a drug and CNV1014802 in healthy male and female subjects. It is planned to enrol 36 subjects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inhibition of Na<sub>V</sub>1.7: the possibility of ideal analgesics.
Kitano Y, Shinozuka T. · · 2022 · cited 13× · PMID 36092147 · DOI 10.1039/d2md00081d

Verify or expand the search:

Other trials of CNV1014802

Trials testing the same drug.

NCT02359344 — PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers · Phase 1 · completed
NCT01540630 — A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia · Phase 2 · completed
NCT01561027 — Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy · Phase 2 · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Biogen trials

Trials by the same sponsor.

NCT07483632 — A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses · Phase 3 · not yet recruiting
NCT06628687 — A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it Duri · recruiting
NCT07444450 — A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy · Phase 3 · not yet recruiting
NCT07444489 — A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants · Phase 3 · not yet recruiting
NCT07444476 — A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years Wit · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02551497 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Biogen
Last refreshed: 16 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02551497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing